Michael Shankman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Shankman
Michael Shankman is recorded as CFO at Lexaria Bioscience Corp. (LEXX). Lexaria Bioscience Corp. reported in an 8-K filed October 2, 2024 that Michael Shankman was appointed Chief Financial Officer, effective October 1, 2024.
“Effective October 1, 2024, Michael Shankman, age 64, has been appointed to the position of Chief Financial Officer of Lexaria Bioscience Corp. (the "Company") replacing Lexaria's former CFO, Nelson Cabatuan who resigned effective July 15, 2024 and assuming the position of principal financial officer and principal accounting officer previously assumed by the Company's CEO, Richard Christopher.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lexaria Bioscience Corp.
Other people whose current roles at this company are on record from its filings.
- Richard Christopher CEO, Board Member
- Christopher Bunka Chairman
- Nelson Cabatuan CFO
- Al Reese Board Member
- Albert Reese Jr Board Member
- Bal Bhullar Board Member
- Catherine C. Turkel Board Member
- Chris Bunka Board Member
- John Docherty Board Member
- Nicholas Baxter Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.